Editorial from Editor-in-Chief (Pulmonary Histoplasmosis in Immunocompetent and Immunocompromised Patients)

Ilse   M.   Espina; Joseph   C.   Gathe Jr.; Joseph      Varon

Author(s): Ilse M. Espina, Joseph C. Gathe Jr. and Joseph Varon

Volume 8, Issue 5, 2012

Page: [343 - 344] Pages: 2

DOI: 10.2174/157339812803832458

Download Options

Rights & Permissions Print Cite

Current Respiratory Medicine Reviews

Title:Editorial from Editor-in-Chief (Pulmonary Histoplasmosis in Immunocompetent and Immunocompromised Patients)

Volume: 8 Issue: 5

Author(s): Ilse M. Espina, Joseph C. Gathe Jr. and Joseph Varon

Affiliation:

Export Options

Export File:

RIS (for EndNote, Reference Manager, ProCite)

BibTeX

Text

Content:

Citation Only

Citation and Abstract

About this article

Cite this article as:

Espina M. Ilse, Gathe Jr. C. Joseph and Varon Joseph, Editorial from Editor-in-Chief (Pulmonary Histoplasmosis in Immunocompetent and Immunocompromised Patients), Current Respiratory Medicine Reviews 2012; 8 (5) . https://dx.doi.org/10.2174/157339812803832458

DOI https://dx.doi.org/10.2174/157339812803832458	Print ISSN 1573-398X
Publisher Name Bentham Science Publisher	Online ISSN 1875-6387

About this journal

Call for Papers in Thematic Issues

Submission closes on : 28 April, 2024

Exposure to PM2.5 components is associated with respiratory diseases

Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more

Guest Editor(s): Dr. Mario Sznol